Nanomedicines Bearing an Alkylating Cytostatic Drug from the Group of 1,3,5-Triazine Derivatives: Development and Characterization

Cancer is still one of the major diseases worldwide. The discovery of new drugs and the improvement of existing ones is one of the areas of priority in the fight against cancer. Dioxadet ([5-[[4,6-bis(aziridin-1-yl)-1,3,5-triazin-2-yl]amino]-2,2-dimethyl-1,3-dioxan-5-yl]methanol) represents one of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinitsyna, Ekaterina, Bagaeva, Irina, Gandalipov, Erik, Fedotova, Evgenia, Korzhikov-Vlakh, Viktor, Tennikova, Tatiana, Korzhikova-Vlakh, Evgenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694467/
https://www.ncbi.nlm.nih.gov/pubmed/36432699
http://dx.doi.org/10.3390/pharmaceutics14112506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694467/
https://www.ncbi.nlm.nih.gov/pubmed/36432699
http://dx.doi.org/10.3390/pharmaceutics14112506

Ejemplares similares